Organ Preservation Industry Set for Striking 6.4% CAGR, Expected to Exceed US$ 455 Million by 2032 | Finds FMI Study

By 2032, the Organ Preservation Industry will be worth US$ 455 million, expanding at a compound annual growth rate of 6.4%. Organ preservation is the act of conserving healthy donor organs so they can be transplanted into the bodies of recipients. Static cold storage (SCS), which stops toxic metabolites from destroying healthy tissue, helps to sustain normal organ function following transplantation.

Organ Preservation Market Overview:

The act of keeping healthy organs after they have been removed from donors’ bodies is known as organ preservation. Without causing much harm, organs are removed from the donor’s body, transported, and then transplanted into the body of the recipient. The results of this study indicate that the adoption of organ preservation is directly impacted by the increased prevalence of chronic illnesses.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14363

Organ preservation for transplantation has a strong influence on donor organ quality, which has a direct impact on a patient’s morbidity and survival rates following transplantation. One of the major factors driving the growth of the organ preservation solutions market is the increasing prevalence of chronic illnesses, as well as the world’s growing elderly population.

Because of the increasing number of organ failures caused by diabetes, cardiovascular diseases (CVDs), obesity, and other serious medical problems, static cold storage organ preservation treatments are becoming more common. Innovative and sophisticated organ preservation strategies, such as NMP, act as a growth-inducing agent.

In clinical and experimental research, such strategies help to reduce the risk of reperfusion damage after transplantation and improve static cold storage organ preservation results. Furthermore, an increasing number of government and non-government regulations and activities to encourage organ donation are positively impacting the growth of the organ preservation solutions market.

The growing number of people who volunteer to donate their organs for transplantation and research is also propelling the market forward. Other factors, such as increased R&D and significant developments in the global organ preservation market, are expected to significantly contribute to market expansion.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-14363

Key Takeaways:

• A preservation injury occurs when the liver no longer functions. A liver transplant, also known as a hepatic transplant, has the potential to save someone’s life. A liver transplant may also be recommended by a doctor to a patient who has reached the end stage of liver disease.
• Individuals who received a liver transplant had an 89% chance of survival after one year, according to an article published in the American Journal of Transplantation. The growing need for organ transplantation is propelling the global organ preservation market across the board.
• According to the American Transplant Foundation, approximately 114,000 people in the United States are currently on the waiting list for a life-saving organ transplant. Every day, on average, 20 people die due to a lack of available organs for transplantation.

Competition Analysis:

The global organ preservation market is dominated by companies such as Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut (Netherlands).

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-14363

Key Market Segments Covered in the Study:

By Solution:

• University of Wisconsin Solution (UW Solution)
• Custodial HTK
• Perfadex
• Other Solutions

By Technique:

• Static Cold Storage
• Hypothermia Machine Perfusion
• Normothermic Machine Perfusion

By Organ Type:

• Kidney
• Liver
• Long
• Heart
• Pancreas

By End User:

• Organ Transplant Centres
• Hospitals
• Speciality Clinics

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube